Positive results of a phase 2 study support the potential to repurpose intranasal insulin and the SGLT2 inhibitor ...

"We showed people with Alzheimer's disease have more gut inflammation," University of Wisconsin psychologist Barbara Bendlin ...

After some time, early symptomatic Alzheimer's disease begins with a small amount of memory loss and confusion that can be ...

The Alzheimer's disease drug Kisunla will face major reimbursement challenges in the U.K. after the cost-effectiveness ...

Each episode of this journey through a disease state contains both a physician guide and a downloadable/printable patient ...

Nearly 7 million Americans 65 and older are living with Alzheimer’s disease, which gradually destroys memory and thinking ...

Diagnosis of Alzheimer's Disease (AD) is currently largely based on the presence of biomarkers. This may lead to a problematic over-diagnosis if this is incorrectly interpreted.

Semaglutide, the weight management drug sold as Ozempic and Wegovy, may reduce the risk of Alzheimer's disease by 40% to 70% ...

The Alzheimer's Association says more than 122,000 Missourians 65 years and older are battling Alzheimer's Disease, which has ...

A new study reveals that the active ingredient in drugs like Ozempic and Wegovy could lower the risk of developing ...

The Northeastern New York chapter of the Alzheimer's Association held it's 2024 Walk to End Alzheimer's at the Clark Sports ...

The National Institutes of Health reports that incidences of Alzheimer's disease and other dementia increased by roughly 148 ...